Stocktoria

LivaNova PLC LIVN

Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2015-10-19
Chart by TradingView
4/9
Piotroski F — financial health
0.72
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$4.6B
P / S3.3×
P / B3.8×
P / FCF26.4×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$1.4B$1.3B$1.2B$1.0B$1.0B
Gross profit$939.9M$853.5M$755.8M$707.2M$706.0M
Operating income$199.4M$129.1M-$68.5M-$76.8M-$784,000
Net income-$242.5M$63.2M$17.5M-$86.2M-$135.8M
Operating cash flow$254.3M$183.0M$74.9M$69.9M$102.5M
Free cash flow$173.3M$135.9M$39.9M$43.4M$77.1M
Total assets$2.6B$2.5B$2.4B$2.3B$2.2B
Total liabilities$1.4B$1.2B$1.2B$1.1B$906.3M
Shareholders' equity$1.2B$1.3B$1.3B$1.2B$1.3B
Ratios
Gross margin67.7%68.1%65.5%69.2%68.2%
Operating margin14.4%10.3%-5.9%-7.5%-0.1%
Net margin-17.5%5.0%1.5%-8.4%-13.1%
FCF margin12.5%10.8%3.5%4.2%7.4%
Return on assets-9.3%2.5%0.7%-3.8%-6.2%
Return on equity-20.2%4.8%1.4%-7.1%-10.5%
Debt / equity0.31×0.47×0.46×0.43×0.01×
Current ratio1.362.872.952.980.97
Revenue growth10.7%8.7%12.9%-1.3%10.8%

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.72 (distress)

  • Working capital / assets 0.113
  • Retained earnings / assets -0.44
  • EBIT / assets 0.077
  • Equity / liabilities 0.853

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001639691 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.